Radiation therapy can promote the epidermal growth factor receptor (EGFR) ligand amphiregulin, which increases growth of ...

Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone ...

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...

Actor Jin Tae-hyun reported on the cure of cancer.Jin Tae-hyun went to the hospital to check-up two weeks after the surgery ...

I am a healthy 89-year-old United States Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was ...

I am a healthy 89-year-old Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was treated with ...

Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in ...

ESTEVE has entered into an agreement with Sanofi to acquire Caprelsa® (vandetanib) rights in more than 50 countries, a ...

Differentiated thyroid cancers with distantmetastases are not common, and even rarer is the initial presentation with complaints not related to the neck. Objectives The objective of this series was to ...

J. Randolph (Randy) Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

Theranostics – an approach that combines the power of radiotherapy with diagnostics – is changing how we treat prostate cancer, especially in advanced stages.

Alteration of tumor immune environment in metastatic and non-metastatic papillary thyroid microcarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025 ...